financetom
Business
financetom
/
Business
/
Keysight Posts Surprising Fiscal Q4 Strength in Orders, Margins, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Keysight Posts Surprising Fiscal Q4 Strength in Orders, Margins, Morgan Stanley Says
Nov 25, 2025 8:30 AM

11:10 AM EST, 11/25/2025 (MT Newswires) -- Keysight Technologies ( KEYS ) delivered stronger-than-expected fiscal Q4 results, supported by solid demand across all major segments and a rising contribution from AI in its wireline business, Morgan Stanley said Tuesday in a report.

Keysight ( KEYS ) "surprised us with the strength" of fiscal Q4 orders and margins, the report said. "The breadth of upside across the businesses, and quicker tariff mitigation, positions the company better heading into FY26 than contemplated."

Orders rose 14% to $1.5 billion, driven by strength across its electronic industrial solutions group and aerospace and defense segment, while AI accounted for about half of wireline demand, or 12% of revenue, the report said.

Morgan Stanley raised its fiscal 2026 earnings estimate to $7.96 a share from $7.78 and boosted the revenue outlook to $6.15 billion from $5.65 billion.

The firm raised its price target on Keysight ( KEYS ) stock to $208 from $180 and maintained its equal weight rating.

Keysight ( KEYS ) shares rose 7.4% in recent Tuesday trading.

Price: 190.83, Change: +13.16, Percent Change: +7.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
Jan 15 (Reuters) - Gilead Sciences ( GILD ) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the...
Senators demand US trade chief Tai halt late talks on investor protections
Senators demand US trade chief Tai halt late talks on investor protections
Jan 15, 2025
WASHINGTON (Reuters) - A bipartisan group of U.S. senators on Wednesday called on U.S. Trade Representative Katherine Tai to stop secret negotiations with Mexico, Canada and Colombia that would weaken investor protections in some U.S. free trade deals during the Biden administration's final days. The letter, led by Senate Finance Committee Chairman Mike Crapo, a Republican, and the panel's top...
Automotive Properties REIT Declares January 2025 Distribution
Automotive Properties REIT Declares January 2025 Distribution
Jan 15, 2025
03:49 PM EST, 01/15/2025 (MT Newswires) -- Automotive Properties REIT (APR-UN.TO) Wednesday declared a distribution of $0.067 per REIT unit for the month of January, representing $0.804 per REIT unit on an annualized basis. This is consistent with December's cash distribution. Payment will be made on Feb. 18 to unitholders of record on Jan. 31. Price: 10.66, Change: +0.08, Percent...
Copyright 2023-2025 - www.financetom.com All Rights Reserved